Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.36 |
| ▸ | DRD4 | P21917 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | ALKBH5 | Q6P6C2 | 2/20 | 0.33 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | NPEPPS | P55786 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25683029 | 0.88 | ALOX5 (0.36) | ALOX5DRD4KDM4ERAB9ANPC1 | |
| SCHEMBL25997529 | 0.86 | ALOX5 (0.37) | ALOX5DRD4KDM4ERAB9ANPC1 | |
| SCHEMBL25997645 | 0.85 | ALKBH5 (0.35) | KDM4ERAB9AALKBH5FTOALDH1A1 | |
| SCHEMBL25682836 | 0.82 | UTS2R (0.38) | KDM4ERAB9ANPC1ALDH1A1MEN1 | |
| SCHEMBL25682222 | 0.81 | RAB9A (0.37) | ALOX5DRD4KDM4ERAB9ANPC1 | |
| SCHEMBL25997494 | 0.80 | GPR3 (0.40) | KDM4ERAB9AALDH1A1MEN1TSHR | |
| SCHEMBL25683374 | 0.79 | CYP1A2 (0.40) | KDM4ERAB9ANPC1ALDH1A1TSHR | |
| SCHEMBL25682955 | 0.79 | ALKBH5 (0.36) | KDM4ERAB9AALKBH5FTOALDH1A1 | |
| SCHEMBL13183691 | 0.79 | GPR3 (0.47) | KDM4EALDH1A1MEN1TSHRKMT2A | |
| SCHEMBL25682055 | 0.78 | MEN1 (0.39) | ALOX5DRD4KDM4ERAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230265106-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT | KYULUX, INC. (JP) | 2023-08-24 | — | — | US | disclosed |
| EP-4190791-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT | Kyulux, Inc. (JP) | 2023-06-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265106-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT | CRY1, CCNE2, CRY2 | ALOX5 2095/4885DRD4 56/4885KDM4E 1997/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.